Sasha G. Demeulenaere

Sasha G. Demeulenaere

Auto-generated profile, based on publicly available information

Sasha G. Demeulenaere

Department of Cell and Molecular Physiology, Stritch School of Medicine, Loyola University Chicago, Maywood, IL

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2019 in Cell Chemical Biology
Verified
Journal Article
Closed access
CBCharles A. Berdan
Charles A. Berdan
RHRaymond Ho
Raymond Ho
HLHaley S. Lehtola
Haley S. Lehtola
MTMilton To
Milton To
XHXirui Hu
Xirui Hu
DNDaniel K. Nomura
Daniel K. Nomura

1 February 2024 in JCO Global Oncology
Verified
Journal Article
Open access
KLKatie E. Lichter
Katie E. Lichter
ASAli Sabbagh
Ali Sabbagh
SDSasha Demeulenaere
Sasha Demeulenaere
TDTaylor Drew
Taylor Drew
ACAlexandra Conway
Alexandra Conway
OMOsama Mohamad
Osama Mohamad
PURPOSE: We aimed to examine the impact of different conference formats (in-person, virtual, and hybrid) of the ASCO conference on greenhouse gas (GHG) emissions and to recommend sustainable options for future conferences. MATERIALS AND METHODS: This study used data on the number of attendees, their departure locations, and the type of attendance (in-person v virtual) provided by ASCO between 2019 and 2022. The GHG emissions resulting from air and ground travel, remote connectivity, conference space utilization, hotel stays, distributed conference materials, and electricity use were estimated for each year. Emissions were stratified by attendee country of origin, type of attendance, and year. Simulations were conducted to evaluate how changes in conference size, location, and format impact emissions, as well as estimate the resulting mitigations from adopting the proposed changes. RESULTS: The highest estimated GHG emissions, calculated in carbon dioxide equivalents (CO2e), were associated with the 2019 in-person conference (37,251 metric tons of CO2e). Although international attendees had the largest contribution to emissions in all years (>50%), location optimization models, which selected conference locations that most minimized GHG emissions, yielded only minimal reductions (approximately 3%). Simulations examining changes to the conference format, location, and attendance percentage suggested that hub-and-spoke, where multiple conference locations are selected by global region, or hybrid models, with both in-person and virtual components, are likely to cause the largest drops in emissions (up to 86%). CONCLUSION: Using historical conference data, this study identifies key aspects that can be modified to reduce emissions and consequently promote more sustainable and equitable conference attendance. Hybrid conferences may be the best solution to maintain the networking opportunities provided by conferences while balancing out their environmental footprint.

14 April 2024 in Pediatric and Developmental Pathology
Verified
Journal Article
Closed access
MOMichaela O’nEil
Michaela O’nEil
SDSasha K. Demeulenaere
Sasha K. Demeulenaere
PDPhillip J. DeChristopher
Phillip J. DeChristopher
EHEmily Holthaus
Emily Holthaus
WJWalter Jeske
Walter Jeske
JMJonathan Muraskas
Jonathan Muraskas
The goal of this investigation was to identify the association between Syndecan-1 (S1) serum levels in preterm newborns exposed to chorioamnionitis (CA) in utero and the potential of S1 as a biomarker of early-onset neonatal sepsis. A cohort of preterm newborns born <33 weeks gestational age was recruited. Within 48 hours of birth, 0.5 mL of blood was drawn to obtain S1 levels, measured via ELISA. Placentas were examined and classified as having (1) no CA, (2) CA without umbilical cord involvement, or (3) CA with inflammation of the umbilical cord (funisitis). S1 levels were compared between preterm newborns without exposure to CA verus newborns with exposure to CA (including with and without funisitis). Preterm newborns exposed to CA were found to have significantly elevated S1 levels compared to those unexposed. Although S1 levels could not differentiate fetal exposure to CA from exposure to CA with funisitis, the combined CA groups had significantly higher S1 levels compared to those not exposed to CA. S1 level has the potential to become a clinically useful biomarker that could assist in the management of mothers and preterm newborns with CA and funisitis. Furthermore, S1 level could aid in the diagnosis and treatment of early-onset neonatal sepsis.

11 October 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
MBMargaret A. Bennett
Margaret A. Bennett
SDSasha G. Demeulenaere
Sasha G. Demeulenaere
HWHuini Wu
Huini Wu
HPHiral Patel
Hiral Patel
SSStefano Sala
Stefano Sala
JBJordan R. Beach
Jordan R. Beach
Vascular smooth muscle cells (SMCs) line blood vessels throughout the body, where they dynamically alter vessel diameter to regulate blood pressure, provide structural integrity, and absorb shock on a beat-to-beat timescale. As smooth muscle function fails, profound vascular disease ensues, often with tragic results- even death. Smooth muscle myosin 2 (SM2) is the dominant motor protein that actuates contractility and allows SMCs to perform these vital functions. To function, SM2 monomers dynamically assemble into filaments, which upon SMC activation, associate with filamentous actin to drive contractility. Despite the critical contribution of SM2 to SMC function, foundational aspects of SM2 assembly and dynamics remain unexplored. To remedy this, we expressed EGFP-tagged SM2 in rat aortic smooth muscle cells (A7R5), which retained a cytosolic calcium and contractile response to the acetylcholine agonist carbachol. Using fluorescence recovery after photobleaching (FRAP), we observed rapid polymer exchange kinetics for SM2, more similar to non-muscle myosin 2 (NM2) than striated myosin 2s. Consistently, super-resolution imaging of SM2 and NM2 suggests they form filamentous co-polymers. Using a single cell filament assembly assay, we observed that the majority of SM2 is assembled in filaments at steady-state, but that SMC activation with carbachol rapidly increases SM2 assembly levels. Carbachol also reduced polymer exchange kinetics, suggesting stabilization of filaments during SMC activation. This carbachol-induced increase in SM2 assembly and decrease in exchange kinetics closely parallels the cytosolic calcium and contractility kinetics. Collectively, our data supports an updated model in which highly dynamic SM2 filaments assemble, are stabilized, and are activated to produce cell-scale contractile forces during SMC activation.

1 September 2026 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Open access
SDSasha K. Demeulenaere
Sasha K. Demeulenaere
MBMargaret A. Bennett
Margaret A. Bennett
BSBradley Somerfield
Bradley Somerfield
HWHuini Wu
Huini Wu
MUMargaret E. Utgaard
Margaret E. Utgaard
JBJordan R. Beach
Jordan R. Beach
BACKGROUND: Vascular smooth muscle cells (SMCs) dynamically tune blood vessel diameter to regulate blood pressure, provide vessel wall structural integrity, and absorb shock on a beat-to-beat timescale. SMII (smooth muscle myosin 2) is the dominant motor protein driving SMC contraction. To function, SMII monomers dynamically assemble into filaments, which associate with the actin cytoskeleton to drive contractility. Precisely how SMII filaments assemble and exchange in living SMCs, however, both at steady state and during induced contractility, remains poorly defined. METHODS: We used a single-cell filament assembly assay to determine SMII assembly into filaments at steady state and upon induced contractility in rat aortic SMCs (A7r5) transiently expressing EGFP (enhanced green fluorescent protein)-tagged SM1A (SMII isoform 1A). We then used fluorescence recovery after photobleaching (FRAP) to characterize SMII exchange kinetics at steady state and upon induced contractility, and measured changes in force production using traction force microscopy. Finally, we developed a knock-in EGFP-SMII murine model to quantify SMII dynamics at endogenous expression in primary SMCs and intact arterioles. RESULTS: While predominantly filamentous at baseline, induced contraction rapidly increased SMII filament assembly. Fluorescence recovery after photobleaching revealed rapid SMII exchange kinetics, more similar to nonmuscle myosin II than striated myosin II, and induced contractility consistently stabilized SMII filaments. Super-resolution imaging revealed SMII and nonmuscle myosin II filament structures consistent with coassembly. Endogenous EGFP-SMII in primary SMCs and intact arterioles paralleled cell culture studies with similar baseline exchange kinetics and activation-dependent stabilization. CONCLUSIONS: Together, these data support a model in which SMII is surprisingly dynamic and coassembles with nonmuscle myosin II. Vascular SMC activation further increases SMII filament assembly while reducing filament exchange, consistent with stabilization of a dynamic SMII pool during force generation, thereby allowing cells to dynamically adapt their overall contractility in response to environmental conditions.